The government announced on 15th that it would support the development of more than three pharmaceutical and biotechnology unicorns (unlisted companies with a corporate value of over 1 trillion ...

TD Cowen has recently raised Sana Biotechnology Inc (SANA) stock to Buy rating, as announced on January 8, 2025, according to Finviz. Earlier, on November 5, 2024, JMP Securities had reduced the stock ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...